对抗瘤免疫力的洞察
Saumya Jani1, Candice D Church1, Paul Nghiem1,2
1Department of Medicine, University of Washington, Seattle, WA, United States.
Frontiers in immunology
|June 8, 2023
概括
默克尔细胞癌 (MCC) 是一种由病毒驱动的癌症,为瘤免疫提供了洞察力. 研究MCC及其免疫逃避机制可以推进其他缺乏共享瘤抗原的癌症的癌症免疫疗法.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 大多数癌症都有独特的突变,阻碍了癌症特异性免疫力.
- 病毒驱动的瘤,如默克尔细胞癌 (MCC),存在共享的抗原,为研究抗瘤免疫提供了一个模型.
- MCC是由默克尔细胞多瘤病毒 (MCPyV) 基蛋白驱动的,这些瘤对瘤存活至关重要,并引起强大的T细胞反应.
研究的目的:
- 要总结从病毒阳性MCC.中抗瘤T细胞反应中学到的教训.
- 审查MCC中的免疫逃避机制和对基于免疫疗法的耐药性.
- 讨论新型工具如何解决癌症免疫治疗中的开放问题.
主要方法:
- 利用20多种-MHC I类四重体来研究MCC患者的抗瘤免疫力.
- 分析MCC中的免疫逃避策略,包括MHC下调和PD-L1上调.
- 审查MCC和其他癌症中对PD-1阻塞的抵抗机制.
主要成果:
- MCPyV基蛋白是不变的和免疫的,在MCC中驱动强大的T细胞反应.
- MCC瘤使用免疫逃避机制,如MHC下调和PD-L1上调.
- 大约50%的晚期MCC患者无法从PD-1阻塞中获得持久的益处.
结论:
- 调查MCC提供了对瘤免疫的宝贵见解,适用于没有共享抗原的癌症.
- 了解MCC的免疫逃避和治疗抵抗机制对于改善癌症免疫治疗至关重要.
- 开发的工具有助于研究抗瘤免疫,并可以解决该领域的关键问题.
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Cytotoxic T Cells-mediated Immune Response
1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Vaccines
435
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
435


